Raymond James & Associates’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$15.7M Buy
273,591
+127,330
+87% +$7.29M 0.01% 953
2024
Q2
$7.66M Buy
146,261
+49,923
+52% +$2.61M 0.01% 1323
2024
Q1
$3.92M Buy
96,338
+25,674
+36% +$1.04M ﹤0.01% 1750
2023
Q4
$2.61M Sell
70,664
-6,657
-9% -$246K ﹤0.01% 1932
2023
Q3
$2.95M Sell
77,321
-583
-0.7% -$22.3K ﹤0.01% 1776
2023
Q2
$2.81M Sell
77,904
-29,073
-27% -$1.05M ﹤0.01% 1845
2023
Q1
$4.09M Buy
106,977
+2,577
+2% +$98.4K ﹤0.01% 1598
2022
Q4
$5.94M Buy
104,400
+29,546
+39% +$1.68M 0.01% 1299
2022
Q3
$2.96M Buy
74,854
+33,149
+79% +$1.31M ﹤0.01% 1723
2022
Q2
$1.84M Buy
41,705
+8,304
+25% +$365K ﹤0.01% 2031
2022
Q1
$1.33M Sell
33,401
-17,793
-35% -$710K ﹤0.01% 2399
2021
Q4
$2.06M Buy
51,194
+16,049
+46% +$645K ﹤0.01% 2151
2021
Q3
$1.43M Sell
35,145
-662
-2% -$26.9K ﹤0.01% 2341
2021
Q2
$1.63M Buy
35,807
+5,597
+19% +$254K ﹤0.01% 2244
2021
Q1
$1.26M Sell
30,210
-17,940
-37% -$748K ﹤0.01% 2339
2020
Q4
$2.06M Buy
48,150
+17,585
+58% +$751K ﹤0.01% 1872
2020
Q3
$803K Buy
30,565
+7,922
+35% +$208K ﹤0.01% 2304
2020
Q2
$607K Buy
22,643
+645
+3% +$17.3K ﹤0.01% 2454
2020
Q1
$396K Sell
21,998
-1,815
-8% -$32.7K ﹤0.01% 2570
2019
Q4
$422K Buy
23,813
+84
+0.4% +$1.49K ﹤0.01% 2833
2019
Q3
$368K Buy
+23,729
New +$368K ﹤0.01% 2855
2018
Q4
Sell
-14,988
Closed -$272K 3493
2018
Q3
$272K Buy
14,988
+1,837
+14% +$33.3K ﹤0.01% 3083
2018
Q2
$222K Buy
+13,151
New +$222K ﹤0.01% 3185
2018
Q1
Sell
-10,685
Closed -$216K 3384
2017
Q4
$216K Buy
+10,685
New +$216K ﹤0.01% 2989
2016
Q4
Sell
-11,770
Closed -$142K 3130
2016
Q3
$142K Buy
11,770
+100
+0.9% +$1.21K ﹤0.01% 2904
2016
Q2
$101K Sell
11,670
-300
-3% -$2.6K ﹤0.01% 2781
2016
Q1
$113K Hold
11,970
﹤0.01% 2681
2015
Q4
$207K Sell
11,970
-4,600
-28% -$79.5K ﹤0.01% 2311
2015
Q3
$223K Buy
16,570
+370
+2% +$4.98K ﹤0.01% 2223
2015
Q2
$366K Sell
16,200
-14,050
-46% -$317K ﹤0.01% 2207
2015
Q1
$432K Buy
30,250
+2,850
+10% +$40.7K ﹤0.01% 2093
2014
Q4
$264K Buy
27,400
+3,700
+16% +$35.7K ﹤0.01% 2146
2014
Q3
$216K Buy
23,700
+1,500
+7% +$13.7K ﹤0.01% 2125
2014
Q2
$219K Buy
22,200
+5,800
+35% +$57.2K ﹤0.01% 2133
2014
Q1
$208K Buy
16,400
+400
+3% +$5.07K ﹤0.01% 2056
2013
Q4
$240K Buy
+16,000
New +$240K ﹤0.01% 1908